tiprankstipranks
Trending News
More News >
OncoZenge AB (DE:8LY)
:8LY

OncoZenge AB (8LY) Price & Analysis

Compare
0 Followers

8LY Stock Chart & Stats


Financials

8LY FAQ

What was OncoZenge AB’s price range in the past 12 months?
OncoZenge AB lowest stock price was €0.26 and its highest was €0.99 in the past 12 months.
    What is OncoZenge AB’s market cap?
    OncoZenge AB’s market cap is €5.81M.
      When is OncoZenge AB’s upcoming earnings report date?
      OncoZenge AB’s upcoming earnings report date is May 20, 2025 which is 17 days ago.
        How were OncoZenge AB’s earnings last quarter?
        OncoZenge AB released its earnings results on Feb 20, 2025. The company reported -€0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.02.
          Is OncoZenge AB overvalued?
          According to Wall Street analysts OncoZenge AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does OncoZenge AB pay dividends?
            OncoZenge AB does not currently pay dividends.
            What is OncoZenge AB’s EPS estimate?
            OncoZenge AB’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does OncoZenge AB have?
            OncoZenge AB has 11,713,244 shares outstanding.
              What happened to OncoZenge AB’s price movement after its last earnings report?
              OncoZenge AB reported an EPS of -€0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.167%.
                Which hedge fund is a major shareholder of OncoZenge AB?
                Currently, no hedge funds are holding shares in DE:8LY

                Company Description

                OncoZenge AB

                OncoZenge AB (publ), a pharmaceutical company, develops healthcare products for cancer supportive care. It offers BupiZenge, which has completed Phase 2 clinical trial for the treatment of oral mucositis. The company was founded in 2020 and is headquartered in Bromma, Sweden. OncoZenge AB (publ) is a subsidiary of Moberg Pharma AB (publ).
                Similar Stocks
                Company
                Price & Change
                Follow
                Biosergen AB
                Modus Therapeutics Holding AB
                Spago Nanomedical AB
                CombiGene AB
                Sprint Bioscience AB
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis